Trial Profile
A retrospective study investigating the chances of withdrawal associated with abatacept intravenous and factors related to survival of treatment in patients with Rheumatoid Arthritis, Psoriatic Arthritis and Juvenile Idiopathic Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Juvenile rheumatoid arthritis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- 29 Jul 2015 New trial record
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.